30.97
price down icon0.93%   -0.29
pre-market  Vorhandelsmarkt:  31.02   0.05   +0.16%
loading
Schlusskurs vom Vortag:
$31.26
Offen:
$31.525
24-Stunden-Volumen:
5.75M
Relative Volume:
0.55
Marktkapitalisierung:
$11.98B
Einnahmen:
$3.14B
Nettoeinkommen (Verlust:
$-3.36B
KGV:
-3.5475
EPS:
-8.73
Netto-Cashflow:
$-4.03B
1W Leistung:
-5.78%
1M Leistung:
+19.58%
6M Leistung:
-13.71%
1J Leistung:
-74.43%
1-Tages-Spanne:
Value
$30.88
$32.07
1-Wochen-Bereich:
Value
$30.88
$33.31
52-Wochen-Spanne:
Value
$23.15
$125.68

Moderna Inc Stock (MRNA) Company Profile

Name
Firmenname
Moderna Inc
Name
Telefon
(617) 714-6500
Name
Adresse
325 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
5,800
Name
Twitter
@moderna_tx
Name
Nächster Verdiensttermin
2025-02-14
Name
Neueste SEC-Einreichungen
Name
MRNA's Discussions on Twitter

Vergleichen Sie MRNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MRNA
Moderna Inc
30.97 12.71B 3.14B -3.36B -4.03B -8.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-13 Eingeleitet Citigroup Neutral
2025-02-18 Herabstufung Barclays Overweight → Equal Weight
2025-01-29 Herabstufung Goldman Buy → Neutral
2024-12-18 Herabstufung Argus Buy → Hold
2024-12-10 Fortgesetzt BofA Securities Underperform
2024-11-19 Eingeleitet Berenberg Hold
2024-11-18 Hochstufung HSBC Securities Hold → Buy
2024-11-15 Eingeleitet Wolfe Research Underperform
2024-10-17 Eingeleitet Bernstein Mkt Perform
2024-09-13 Herabstufung JP Morgan Neutral → Underweight
2024-09-13 Herabstufung Jefferies Buy → Hold
2024-09-13 Herabstufung Oppenheimer Outperform → Perform
2024-08-28 Hochstufung HSBC Securities Reduce → Hold
2024-08-07 Hochstufung Deutsche Bank Sell → Hold
2024-08-05 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Herabstufung HSBC Securities Hold → Reduce
2024-01-02 Hochstufung Oppenheimer Perform → Outperform
2023-11-29 Eingeleitet Canaccord Genuity Hold
2023-11-03 Hochstufung HSBC Securities Reduce → Hold
2023-11-02 Herabstufung Deutsche Bank Hold → Sell
2023-08-04 Herabstufung TD Cowen Outperform → Market Perform
2023-08-03 Herabstufung Deutsche Bank Buy → Hold
2023-07-24 Eingeleitet William Blair Mkt Perform
2023-07-14 Eingeleitet HSBC Securities Reduce
2023-06-26 Hochstufung UBS Neutral → Buy
2023-04-26 Eingeleitet Guggenheim Neutral
2023-03-13 Hochstufung TD Cowen Market Perform → Outperform
2023-03-02 Eingeleitet RBC Capital Mkts Outperform
2023-02-24 Herabstufung SVB Securities Market Perform → Underperform
2022-12-19 Hochstufung Jefferies Hold → Buy
2022-12-14 Herabstufung Chardan Capital Markets Buy → Neutral
2022-10-21 Hochstufung SVB Leerink Underperform → Mkt Perform
2022-09-08 Hochstufung Deutsche Bank Hold → Buy
2022-02-01 Hochstufung Redburn Sell → Neutral
2022-01-26 Hochstufung Deutsche Bank Sell → Hold
2022-01-21 Hochstufung BofA Securities Underperform → Neutral
2022-01-21 Eingeleitet UBS Neutral
2021-12-07 Eingeleitet Cowen Market Perform
2021-11-09 Eingeleitet Wolfe Research Outperform
2021-10-22 Eingeleitet Deutsche Bank Sell
2021-10-15 Hochstufung Piper Sandler Neutral → Overweight
2021-08-06 Herabstufung Oppenheimer Outperform → Perform
2021-08-06 Herabstufung Piper Sandler Overweight → Neutral
2021-07-15 Bestätigt Jefferies Hold
2021-02-01 Herabstufung BofA Securities Neutral → Underperform
2020-12-16 Herabstufung Jefferies Buy → Hold
2020-12-16 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-09 Herabstufung Needham Buy → Hold
2020-11-23 Eingeleitet Wells Fargo Equal Weight
2020-11-17 Herabstufung BMO Capital Markets Outperform → Market Perform
2020-09-08 Herabstufung SVB Leerink Mkt Perform → Underperform
2020-07-23 Eingeleitet SVB Leerink Mkt Perform
2020-07-20 Herabstufung JP Morgan Overweight → Neutral
2020-07-13 Eingeleitet Jefferies Buy
2020-06-30 Eingeleitet Argus Buy
2020-06-08 Eingeleitet Barclays Overweight
2020-04-30 Eingeleitet BMO Capital Markets Outperform
2020-03-05 Herabstufung BofA/Merrill Buy → Neutral
2019-12-03 Fortgesetzt BofA/Merrill Buy
2019-10-25 Eingeleitet ROTH Capital Buy
2019-04-05 Eingeleitet Chardan Capital Markets Buy
Alle ansehen

Moderna Inc Aktie (MRNA) Neueste Nachrichten

pulisher
02:50 AM

Moderna Target of Unusually High Options Trading (NASDAQ:MRNA) - MarketBeat

02:50 AM
pulisher
Jul 21, 2025

New York State Common Retirement Fund Sells 33,365 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jul 21, 2025
pulisher
Jul 21, 2025

What drives Moderna Inc. stock pricePowerful growth strategies - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Lexicography: Clear And Unequivocal - The National Law Review

Jul 21, 2025
pulisher
Jul 21, 2025

Wealthfront Advisers LLC Increases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jul 21, 2025
pulisher
Jul 21, 2025

After Moderna Pulled Its Shot, Combination Flu/COVID Vaccines Hang in Limbo - BioSpace

Jul 21, 2025
pulisher
Jul 20, 2025

What analysts say about Moderna Inc. stockFree Investment Timing Strategies - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Moderna Bets Big On New Vaccines After Stock Tumbles - Finimize

Jul 20, 2025
pulisher
Jul 20, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by South Dakota Investment Council - MarketBeat

Jul 20, 2025
pulisher
Jul 19, 2025

Is Moderna Inc. a good long term investmentRobust investment performance - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Moderna Inc. Stock Analysis and ForecastMarket-beating returns - Jammu Links News

Jul 19, 2025
pulisher
Jul 19, 2025

Edgestream Partners L.P. Has $2.78 Million Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

OVERSEA CHINESE BANKING Corp Ltd Buys 17,268 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jul 19, 2025
pulisher
Jul 18, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Acquired by Nisa Investment Advisors LLC - MarketBeat

Jul 18, 2025
pulisher
Jul 18, 2025

Moderna, Inc. (MRNA) Aktienkurs, Nachrichten, Kurs und Verlauf - yahoo.co

Jul 18, 2025
pulisher
Jul 18, 2025

Here's Why Moderna (MRNA) Fell More Than Broader Market - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

How IBM and Moderna’s partnership could lead to an explosion in drug development - Fast Company

Jul 18, 2025
pulisher
Jul 18, 2025

Moderna cancels plans to build Japan plant on poor business environment - Reuters

Jul 18, 2025
pulisher
Jul 18, 2025

Moderna gets full FDA approval for kids COVID-19 vaccine - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Moderna, Inc.'s (NASDAQ:MRNA) Price Is Right But Growth Is Lacking After Shares Rocket 26% - simplywall.st

Jul 18, 2025
pulisher
Jul 18, 2025

Moderna cancels mRNA production plant in Japan (MRNA:NASDAQ) - Seeking Alpha

Jul 18, 2025
pulisher
Jul 18, 2025

Cwm LLC Purchases 28,831 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jul 18, 2025
pulisher
Jul 17, 2025

Lobbying Update: $120,000 of MODERNA INC. lobbying was just disclosed - Quiver Quantitative

Jul 17, 2025
pulisher
Jul 17, 2025

How IBM and Moderna (MRNA) Are Using Quantum Computing to Design Vaccines Faster - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025 - Amarillo Globe-News

Jul 17, 2025
pulisher
Jul 17, 2025

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease - Knoxville News Sentinel

Jul 17, 2025
pulisher
Jul 17, 2025

IBM-Moderna Showcase Quantum-Enhanced Drug Discovery - HPCwire

Jul 17, 2025
pulisher
Jul 17, 2025

IBM and Moderna Team Up on Quantum Study. What It Means for the World of Medicine. - Barron's

Jul 17, 2025
pulisher
Jul 16, 2025

Director, Strategic Forecasting, Oncology job with Moderna, Inc. | 1402245670 - New Scientist

Jul 16, 2025
pulisher
Jul 16, 2025

Moderna’s latest approval again reveals FDA rift over COVID vaccines - BioPharma Dive

Jul 16, 2025
pulisher
Jul 16, 2025

William Blair Issues Negative Outlook for Moderna Earnings - MarketBeat

Jul 16, 2025
pulisher
Jul 16, 2025

Bank of New York Mellon Corp Purchases 34,034 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Jul 16, 2025
pulisher
Jul 16, 2025

FDA Fully Approves Moderna’s COVID-19 Vaccine for Some Young Children - Vaccine Advisor

Jul 16, 2025
pulisher
Jul 15, 2025

Lobbying Update: $100,000 of MODERNA US INC. lobbying was just disclosed - Quiver Quantitative

Jul 15, 2025
pulisher
Jul 15, 2025

Moderna patent for mRNA vaccine knocked back, for now - Lawyerly

Jul 15, 2025
pulisher
Jul 15, 2025

Moderna: Ready For The Redemption Arc (NASDAQ:MRNA) - Seeking Alpha

Jul 15, 2025
pulisher
Jul 15, 2025

Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA) - Yahoo Finance

Jul 15, 2025
pulisher
Jul 14, 2025

Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash - Yahoo Finance

Jul 14, 2025
pulisher
Jul 14, 2025

Opinion: It's Time to Load Up on This Biotech Giant After Its 80% Crash - The Motley Fool

Jul 14, 2025
pulisher
Jul 14, 2025

What to Expect From Moderna's Next Quarterly Earnings Report - MSN

Jul 14, 2025

Finanzdaten der Moderna Inc-Aktie (MRNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Kapitalisierung:     |  Volumen (24h):